You are here

  • Home
  • Archive
  • Volume 78, Issue 11
  • Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration

Article info

Article menu
Download PDFPDF
Spondyloarthritis
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration

Authors

  1. Correspondence to Dr Cecilie Heegaard Brahe, EuroSpA Coordinating Center, Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark; cecilie.cornelia.heegaard.brahe{at}regionh.dk
View Full Text

Citation

Ørnbjerg LM, Brahe CH, Askling J, et al
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration
Annals of the Rheumatic Diseases 2019;78:1536-1544.

Publication history

  • Received March 24, 2019
  • Revised June 17, 2019
  • Accepted July 13, 2019
  • First published August 20, 2019.
Online issue publication 
May 12, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.